We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYY icon
226
First Trust Cloud Computing ETF
SKYY
$2.86B
$5.56M 0.1%
52,766
-3,790
-7% -$407K
SYK icon
227
Stryker
SYK
$133B
$5.51M 0.1%
20,890
-447
-2% -$120K
GE icon
228
GE Aerospace
GE
$368B
$5.5M 0.1%
85,765
-31,776
-27% -$2.04M
CME icon
229
CME Group
CME
$96.1B
$5.49M 0.1%
28,363
+1,951
+7% +$395K
SDY icon
230
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$5.48M 0.1%
46,601
-750
-2% -$91.8K
UI icon
231
Ubiquiti
UI
$32.3B
$5.48M 0.1%
18,333
-62
-0.3% -$19.2K
RIO icon
232
Rio Tinto
RIO
$158B
$5.44M 0.1%
81,378
-32,137
-28% -$2.51M
EVRG icon
233
Evergy
EVRG
$19.2B
$5.42M 0.1%
87,099
-812
-0.9% -$53.2K
DXCM icon
234
DexCom
DXCM
$28.8B
$5.35M 0.1%
39,152
-2,212
-5% -$279K
BP icon
235
BP
BP
$114B
$5.35M 0.1%
195,796
-10,776
-5% -$270K
HUM icon
236
Humana
HUM
$44B
$5.35M 0.1%
13,743
-884
-6% -$375K
RWM icon
237
ProShares Short Russell2000
RWM
$132M
$5.32M 0.1%
245,985
+2,399
+1% +$51.7K
O icon
238
Realty Income
O
$60.1B
$5.26M 0.1%
83,690
+3,061
+4% +$207K
HFRO
239
Highland Opportunities and Income Fund
HFRO
$407M
$5.22M 0.1%
484,755
+16,312
+3% +$175K
BDX icon
240
Becton Dickinson
BDX
$45.6B
$5.21M 0.1%
21,726
+435
+2% +$107K
MAG
241
DELISTED
MAG Silver
MAG
$5.21M 0.1%
321,369
+2,578
+0.8% +$48.2K
EXPD icon
242
Expeditors International
EXPD
$21.8B
$5.16M 0.1%
43,334
-25,901
-37% -$3.24M
FBIN icon
243
Fortune Brands Innovations
FBIN
$5.88B
$5.16M 0.1%
67,542
+24,837
+58% +$2.07M
FITB
244
Fifth Third Bancorp
FITB
$51.3B
$5.15M 0.1%
121,383
+4,312
+4% +$165K
COP icon
245
ConocoPhillips
COP
$145B
$5.14M 0.1%
75,872
+5,702
+8% +$329K
MOAT icon
246
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$5.14M 0.1%
70,140
+3,667
+6% +$276K
HCA icon
247
HCA Healthcare
HCA
$85.7B
$5.14M 0.1%
21,157
+169
+0.8% +$41.3K
ATVI
248
DELISTED
Activision Blizzard
ATVI
$5.13M 0.1%
66,324
-2,268
-3% -$190K
TJX icon
249
TJX Companies
TJX
$176B
$5.11M 0.1%
77,400
-2,390
-3% -$167K
PANW icon
250
Palo Alto Networks
PANW
$265B
$5.1M 0.1%
63,882
+3,198
+5% +$225K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.